Related Experiment Video
Updated: Dec 11, 2025

Bead Aggregation Assays for the Characterization of Putative Cell Adhesion Molecules
Published on: October 17, 2014
Cardiomyocyte adhesion and hyperadhesion differentially require ERK1/2 and plakoglobin
Maria Shoykhet1, Sebastian Trenz1, Ellen Kempf1
1Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Insights
Stabilizing cardiomyocyte adhesion, crucial for preventing arrhythmogenic cardiomyopathy (AC), can be achieved through various signaling pathways. These pathways enhance cell adhesion, offering new therapeutic targets for heart disease.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Adhesion Mechanisms
Background:
- Arrhythmogenic cardiomyopathy (AC) is a heart disease linked to mutations in desmosomal proteins like desmoglein-2 (DSG2), plakoglobin (PG), and desmoplakin (DP).
- Current AC therapies manage symptoms and arrhythmias, as the precise mechanisms of desmosomal proteins in cardiomyocyte function remain unclear.
- Stabilizing desmosomal cardiomyocyte adhesion and hyperadhesion presents a novel therapeutic strategy, potentially making adhesion independent of calcium (Ca2+).
Purpose of the Study:
- To elucidate the signaling pathways that regulate cardiomyocyte adhesion under basal and hyperadhesive conditions.
- To investigate the role of adrenergic signaling, protein kinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), and extracellular signal-regulated kinase 1/2 (ERK1/2) in controlling cell adhesion.
- To examine the impact of plakoglobin (PG) deficiency on these adhesion-regulating mechanisms in the context of AC.
Main Methods:
- Utilized dissociation assays in HL-1 cells and murine ventricular cardiac slice cultures to study cardiomyocyte adhesion.
- Investigated the effects of adrenergic signaling, PKC activation, p38MAPK inhibition, and ERK1/2 activation on cell adhesion.
- Analyzed the recruitment of DSG2 to cell junctions and PG phosphorylation at S665.
- Compared adhesion responses in wild-type and PG-deficient mice with an AC phenotype.
Main Results:
- Adrenergic signaling, PKC activation, and p38MAPK inhibition enhanced cardiomyocyte adhesion (positive adhesiotropy) and induced hyperadhesion.
- ERK1/2 activation correlated with positive adhesiotropy.
- Adrenergic signaling promoted PG phosphorylation at S665 under both basal and hyperadhesive states.
- Adrenergic signaling and p38MAPK inhibition led to increased DSG2 at cell junctions.
- In PG-deficient mice, only PKC activation and p38MAPK inhibition effectively enhanced cardiomyocyte adhesion.
Conclusions:
- Cardiomyocyte adhesion can be modulated and stabilized through distinct signaling pathways.
- These findings highlight potential therapeutic targets for stabilizing desmosomal junctions in AC.
- The efficacy of certain signaling mechanisms in enhancing adhesion is partially dependent on the presence of PG, as observed in AC models.
Abstract:
Arrhythmogenic cardiomyopathy (AC) is a heart disease often caused by mutations in genes coding for desmosomal proteins, including desmoglein-2 (DSG2), plakoglobin (PG), and desmoplakin (DP). Therapy is based on symptoms and limiting arrhythmia, because the mechanisms by which desmosomal components control cardiomyocyte function are largely unknown. A new paradigm could be to stabilize desmosomal cardiomyocyte adhesion and hyperadhesion, which renders desmosomal adhesion independent from Ca2+. Here, we further characterized the mechanisms behind enhanced cardiomyocyte adhesion and hyperadhesion. Dissociation assays performed in HL-1 cells and murine ventricular cardiac slice cultures allowed us to define a set of signaling pathways regulating cardiomyocyte adhesion under basal and hyperadhesive conditions. Adrenergic signaling, activation of PKC, and inhibition of p38MAPK enhanced cardiomyocyte adhesion, referred to as positive adhesiotropy, and induced hyperadhesion. Activation of ERK1/2 paralleled positive adhesiotropy, whereas adrenergic signaling induced PG phosphorylation at S665 under both basal and hyperadhesive conditions. Adrenergic signaling and p38MAPK inhibition recruited DSG2 to cell junctions. In PG-deficient mice with an AC phenotype, only PKC activation and p38MAPK inhibition enhanced cardiomyocyte adhesion. Our results demonstrate that cardiomyocyte adhesion can be stabilized by different signaling mechanisms, which are in part offset in PG-deficient AC.
More Related Videos
09:11Using Cell-substrate Impedance and Live Cell Imaging to Measure Real-time Changes in Cellular Adhesion and De-adhesion Induced by Matrix Modification
Published on: February 19, 2015
07:55Analyzing Cell Surface Adhesion Remodeling in Response to Mechanical Tension Using Magnetic Beads
Published on: March 8, 2017
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Intracellular Signaling Affects Focal Adhesions
Some...
Anchoring Junctions
Desmosomes
Adherens Junctions
Adherens Junctions are Dynamic
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...